BloodSTOP® and BloodSTOP® iX are biocompatible, non-irritating, woven matrices of fibers made from natural plant compounds. They adhere to a wound, initiate blood coagulation, stop bleeding, and form a protective layer to create an optimal environment for wound healing. Their water solubility allows for removal by rinsing, without disruption of a clotted surface.

 

These products are covered by U.S. Patent No. 7,262,181.

 

Clinical Data - US

Multi-Center, Comparative Clinical Assessment of Products for Hemostasis and Wound Healing in Endoscope Sinus Surgery

A comparative clinical assessment was conducted to evaluate the efficacy in tissue healing and symptom improvements of three products of hemostasis and wound healing.

Utilizing a consistent protocol, data were collected from multiple medical center from 2000-2003. A total of 218 patients(318 sides) with chronic sinusitis, type II nastal polyps (II term) and recurrent nasal polyps were treated. Cases were assigned randomly to receive one of the three products of hemostasis. Post-surgical follow ups were carried out over a three to six month period. The primary assessment were tissue healing and symptom improvements.

   For full PDF report, click here.

Healing Evaluations Result:

Group

Cavities

Grade I (%)

Grade II (%)

Grade III (%)

Post-op total washings

A
(BloodSTOP® iX)

118

99 (84.0)

17 (14.4)

2 (1.47)

0-2

B
(Surgical® Hemostat)

120

78 (65.0)

33 (27.5)

9 (7.5)

50

C
(Vaseline® Gauze)

80

52 (65.0)

21 (26.3)

7 (8.75)

50

 

Symptom Improvement Evaluations Result:

Group

Cavities

Grade I (%)

Grade II (%)

Grade III (%)

Post-op total washings

A
(BloodSTOP® iX)

118

108 (91.5)

10 (8.5)

0 (0)

0 (0)

B
(Surgical® Hemostat)

120

88 (73.3)

28 (23.3)

4 (3.5)

0 (0)

C
(Vaseline® Gauze)

80

62 (85.0)

8 (10.0)

4 (5)

6 (7.5)

 

Clinical Experience

Emergency and therapeutic use in the control of bleeding from the skin and other surface wounds where temporary control of bleeding is required.

IVC Filter Jugular Placement